Pieter Busschaert

No ORCID on file · 2 papers in corpus
2025
·doi:10.1016/j.ijgc.2024.100301
other 2021
Genome medicine ·doi:10.1186/s13073-021-00922-x

BACKGROUND: High-grade serous tubo-ovarian cancer (HGSTOC) is characterised by extensive inter- and intratumour heterogeneity, resulting in persistent therapeutic resistance and poor disease outcome. Molecular subtype classification based o…